Back
- 1.Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice
- 2.Metabolomics in combination with network pharmacology reveals the potential anti-neuroinflammatory mechanism of essential oils from four Curcuma species
- 3.A Pathogenic Role for FcγRI in the Immune Response against Chlamydial Respiratory Infection
- 4.Severe hypertriglyceridemia caused by Gpihbp1 deficiency facilitates vascular remodeling through increasing endothelial activation and oxidative stress
- 5.Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
